Popular Filters
Trials for Thyroid Cancer Patients
Protein Kinase Inhibitor
Triple Drug Therapy for Thyroid Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is testing a combo of 3 drugs to treat patients with a specific mutation in their cancer cells. The drugs work by either stopping cell growth or by helping the body's immune system attack the cancer.
Tyrosine Kinase Inhibitor
Lenvatinib + Pembrolizumab for Advanced Thyroid Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is studying how well lenvatinib and pembrolizumab work together to treat patients with anaplastic thyroid cancer that cannot be removed by surgery or has spread to other parts of the body.
Kinase Inhibitor
Dabrafenib + Trametinib + IMRT for Thyroid Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial is testing whether combining dabrafenib, trametinib, and intensity modulated radiation therapy (IMRT) is more effective at treating patients with BRAF mutated anaplastic thyroid cancer than just using IMRT alone.
CAR T-cell Therapy
TIL Therapy for Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial tests a treatment using a patient's own immune cells to fight various cancers that haven't responded to other treatments or have come back. The immune cells are taken from the tumor, grown in a lab, and then reintroduced into the body to target and kill cancer cells. The study aims to see how well this approach works and how safe it is.
Trials for Thyroid Gland Carcinoma Patients
Protein Kinase Inhibitor
Triple Drug Therapy for Thyroid Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is testing a combo of 3 drugs to treat patients with a specific mutation in their cancer cells. The drugs work by either stopping cell growth or by helping the body's immune system attack the cancer.
Tyrosine Kinase Inhibitor
Lenvatinib + Pembrolizumab for Advanced Thyroid Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is studying how well lenvatinib and pembrolizumab work together to treat patients with anaplastic thyroid cancer that cannot be removed by surgery or has spread to other parts of the body.
Kinase Inhibitor
Dabrafenib + Trametinib + IMRT for Thyroid Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial is testing whether combining dabrafenib, trametinib, and intensity modulated radiation therapy (IMRT) is more effective at treating patients with BRAF mutated anaplastic thyroid cancer than just using IMRT alone.
CAR T-cell Therapy
TIL Therapy for Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial tests a treatment using a patient's own immune cells to fight various cancers that haven't responded to other treatments or have come back. The immune cells are taken from the tumor, grown in a lab, and then reintroduced into the body to target and kill cancer cells. The study aims to see how well this approach works and how safe it is.
Trials With No Placebo
Protein Kinase Inhibitor
Triple Drug Therapy for Thyroid Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is testing a combo of 3 drugs to treat patients with a specific mutation in their cancer cells. The drugs work by either stopping cell growth or by helping the body's immune system attack the cancer.
Tyrosine Kinase Inhibitor
Lenvatinib + Pembrolizumab for Advanced Thyroid Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is studying how well lenvatinib and pembrolizumab work together to treat patients with anaplastic thyroid cancer that cannot be removed by surgery or has spread to other parts of the body.
Kinase Inhibitor
Dabrafenib + Trametinib + IMRT for Thyroid Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial is testing whether combining dabrafenib, trametinib, and intensity modulated radiation therapy (IMRT) is more effective at treating patients with BRAF mutated anaplastic thyroid cancer than just using IMRT alone.
CAR T-cell Therapy
TIL Therapy for Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial tests a treatment using a patient's own immune cells to fight various cancers that haven't responded to other treatments or have come back. The immune cells are taken from the tumor, grown in a lab, and then reintroduced into the body to target and kill cancer cells. The study aims to see how well this approach works and how safe it is.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.